It's insulin

Journal of Autoimmunity

Volumn 15, Issue 3, 2000, Pages 286-291

  Wegmann, Dale R ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN; INSULIN ANTIBODY;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0033679598     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0444     Document Type: Review

References (53)

1. Insulin antibodies in insulin-dependent diabetics before insulin treatment
2. Radioassay determination of insulin autoantibodies in NOD mice: Correlation with increased risk of progression to overt diabetes
3. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice
4. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice
5. Analysis of the spontaneous T cell response to insulin in NOD mice
6. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice
7. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
8. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
9. Islet cell autoantigens in insulin-dependent diabetes
10. The pathogenesis of insulin-dependent diabetes mellitus
11. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
12. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
13. GM2-M1 pancreatic islet ganglioside: Identification and characterization of a novel islet-specific molecule
14. Cloning and expression of IDDM-specific human autoantigens
15. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
16. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
17. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes
18. Protein tyrosine phosphatase-like proteins: Link with IDDM
19. Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes
20. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2
21. Molecular cloning of Phogrin, a protein-tyrosine phosphatase homologue localized to insulinsecretory granule membranes
22. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein
23. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein
24. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277
25. The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus
26. T-lymphocyte clone specific for pancreatic islet antigen
27. Pancreatic islet-specific T-cell clones from nonobese diabetic mice
28. + islet-specific T cell clone
29. Nasal administation of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
30. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy
31. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin
32. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group
33. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes
34. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets
35. Glutamate decarboxylase and GABA in pancreatic islets: Lessons from knock-out mice
36. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice
37. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
38. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells
39. Early expression of anti-insulin autoantibodies of man and the NOD mouse: Evidence for early determination of subsequent diabetes
40. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice
41. Characterization of insulin autoantibodies in relatives of patients with Type I diabetes
42. Prediction and prevention of type I diabetes
43. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
44. Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: Sensitive early detection using a protein A/G-based radiobinding assay
45. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse loglinear correlation with age
46. Insulin autoimmunity: The rate limiting factor in pre-type-I diabetes
47. Human T cell clones with specifcity for insulinoma cell antigens
48. T-cell clones from a typed diabetes patient respond to insulin secretory granule proteins
49. Autoimmune versus inflammatory type I diabetes: A controversy?
50. T-cell epitope analysis using subtracted expression libraries (TEASEL): Application to a 38kDa autoantigen recognized by T cells from an insulin-dependent diabetic patient
51. Autoreactive T cell responses in insulin-dependent (Type 1) Diabetes Mellitus. Report of the First International Workshop for Standardization of T cell assays
52. Monoclonal T cells identifiied in early NOD islet infiltrates
53. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain